Neomycin And Polymyxin B Sulfates And Hydrocortisone Suspension/ Drops
Product Images NDC 68788-9924

5 FDA label images from Preferred Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Neomycin And Polymyxin B Sulfates And Hydrocortisone (NDC 68788-9924). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Preferred Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chems (Chems)

Chems (Chems)
Chemical structure diagram showing Neomycin B and Neomycin C, indicating their molecular components and differences in the R1 and R2 groups as labeled.*
FDA Label Image

Chemst (Chemst)

Chemst (Chemst)
Chemical structure diagram showing polymyxin B1 and polymyxin B2, including annotations for R groups and diaminobutyric acid (DAB). The image depicts the molecular structure of polymyxin B, part of the Neomycin and Polymyxin B Sulfates and Hydrocortisone product.*
FDA Label Image

Chemstr (Chemstr)

Chemstr (Chemstr)
Chemical structure diagram of Hydrocortisone, an active ingredient in the product Neomycin and Polymyxin B Sulfates and Hydrocortisone. The image shows the molecular formula C21H30O5 and a molecular weight of 362.46.*
FDA Label Image

Donotuse (Donotuse)

Donotuse (Donotuse)
A boxed warning stating, "DO NOT USE IF IMPRINTED NECKBAND IS NOT INTACT." This is likely part of the packaging or safety information for Neomycin and Polymyxin B Sulfates and Hydrocortisone Otic Suspension/Drops by Preferred Pharmaceuticals, Inc.*
FDA Label Image

Relabeled By: Preferred Pharmaceuticals Inc. (Carton)

Relabeled By: Preferred Pharmaceuticals Inc. (Carton)
Label for Neomycin Polymyxin & Hydrocortisone Otic Suspension by Preferred Pharmaceuticals, Inc. Contains hydrocortisone 10 mg/mL (1%), neomycin sulfate eq. to 3.5 mg base, and polymyxin B sulfate eq. to 10,000 units. Includes directions for use in English and Spanish, caution statement about federal drug transfer law, and manufacturing information by Bausch & Lomb Pharmaceuticals, Tampa, FL. The label also has barcode and warnings.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.